150 related articles for article (PubMed ID: 9850925)
21. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
22. Glia and their cytokines in progression of neurodegeneration.
Mrak RE; Griffin WS
Neurobiol Aging; 2005 Mar; 26(3):349-54. PubMed ID: 15639313
[TBL] [Abstract][Full Text] [Related]
23. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of cell death in Alzheimer disease--immunopathology.
McGeer PL; McGeer EG
J Neural Transm Suppl; 1998; 54():159-66. PubMed ID: 9850924
[TBL] [Abstract][Full Text] [Related]
25. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
26. The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications.
Arranz AM; De Strooper B
Lancet Neurol; 2019 Apr; 18(4):406-414. PubMed ID: 30795987
[TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology.
Obulesu M; Jhansilakshmi M
Int J Neurosci; 2014 Apr; 124(4):227-35. PubMed ID: 23919560
[TBL] [Abstract][Full Text] [Related]
28. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease.
Rogers J; Luber-Narod J; Styren SD; Civin WH
Neurobiol Aging; 1988; 9(4):339-49. PubMed ID: 3263583
[TBL] [Abstract][Full Text] [Related]
29. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
[TBL] [Abstract][Full Text] [Related]
30. Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
von Bernhardi R; Ramirez G
Biol Res; 2001; 34(2):123-8. PubMed ID: 11715204
[TBL] [Abstract][Full Text] [Related]
31. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
[TBL] [Abstract][Full Text] [Related]
32. High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease.
Bouvier DS; Jones EV; Quesseveur G; Davoli MA; A Ferreira T; Quirion R; Mechawar N; Murai KK
Sci Rep; 2016 Apr; 6():24544. PubMed ID: 27090093
[TBL] [Abstract][Full Text] [Related]
33. Activated microglia and cerebral amyloid deposits in Alzheimer's disease.
Rozemuller JM; van der Valk P; Eikelenboom P
Res Immunol; 1992; 143(6):646-9. PubMed ID: 1455057
[No Abstract] [Full Text] [Related]
34. Synergistic actions of microglia and astrocytes in the progression of Alzheimer's disease.
Bouvier DS; Murai KK
J Alzheimers Dis; 2015; 45(4):1001-14. PubMed ID: 25663025
[TBL] [Abstract][Full Text] [Related]
35. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.
Lue LF; Walker DG; Rogers J
Neurobiol Aging; 2001; 22(6):945-56. PubMed ID: 11755003
[TBL] [Abstract][Full Text] [Related]
36. Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients.
Lue LF; Brachova L; Walker DG; Rogers J
Neurobiol Aging; 1996; 17(3):421-9. PubMed ID: 8725904
[TBL] [Abstract][Full Text] [Related]
37. Astroglia in Alzheimer's Disease.
Verkhratsky A; Parpura V; Rodriguez-Arellano JJ; Zorec R
Adv Exp Med Biol; 2019; 1175():273-324. PubMed ID: 31583592
[TBL] [Abstract][Full Text] [Related]
38. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
[TBL] [Abstract][Full Text] [Related]
39. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice.
Benzing WC; Wujek JR; Ward EK; Shaffer D; Ashe KH; Younkin SG; Brunden KR
Neurobiol Aging; 1999; 20(6):581-9. PubMed ID: 10674423
[TBL] [Abstract][Full Text] [Related]
40. Glial cytokines in Alzheimer's disease: review and pathogenic implications.
Mrak RE; Sheng JG; Griffin WS
Hum Pathol; 1995 Aug; 26(8):816-23. PubMed ID: 7635444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
